Charles Schwab Investment Management Inc Aeglea Bio Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $53,405 - $284,114	-106,810 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.87 - $4.77 $13,712 - $34,978	7,333 Added 7.37%	106,810 $246,000
Q3 2021 Nov 16, 2021	SELL	$6.03 - $7.95 $38,001 - $50,100	-6,302 Reduced 5.96%	99,477 $791,000
Q2 2021 Aug 16, 2021	SELL	$6.32 - $8.38 $31,625 - $41,933	-5,004 Reduced 4.52%	105,779 $737,000
Q1 2021 May 17, 2021	SELL	$6.76 - $8.57 $11,093 - $14,063	-1,641 Reduced 1.46%	110,783 $878,000
Q4 2020 Feb 16, 2021	BUY	$7.02 - $9.83 $47,532 - $66,558	6,771 Added 6.41%	112,424 $885,000
Q3 2020 Nov 13, 2020	SELL	$6.51 - $9.33 $20,786 - $29,790	-3,193 Reduced 2.93%	105,653 $750,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $193,626 - $533,077	48,286 Added 79.73%	108,846 $1.01 Million
Q1 2020 May 15, 2020	BUY	$3.51 - $8.48 $3,295 - $7,962	939 Added 1.57%	60,560 $283,000
Q2 2019 Aug 09, 2019	BUY	$6.1 - $8.78 $92,171 - $132,665	15,110 Added 33.95%	59,621 $409,000
Q1 2019 May 14, 2019	BUY	$7.6 - $9.4 $25,467 - $31,499	3,351 Added 8.14%	44,511 $359,000
Q4 2018 Feb 14, 2019	BUY	$6.51 - $10.19 $70,698 - $110,663	10,860 Added 35.84%	41,160 $309,000
Q2 2018 Aug 08, 2018	BUY	$7.87 - $10.89 $238,461 - $329,967	30,300 New	30,300 $321,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.